AD2000: donepezil in Alzheimer's disease.
Schneider
Lon S
LS
Department of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. lschneid@usc.edu
D000203:Activities of Daily Living; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics; D002800:Cholinesterase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D003071:Cognition; D003362:Cost-Benefit Analysis; D000077265:Donepezil; D004345:Drug Industry; D006801:Humans; D007189:Indans / Q000191:economics / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000191:economics / Q000627:therapeutic use*; D010880:Piperidines / Q000191:economics / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D000077265:Donepezil